Drug Type Unknown |
Synonyms- |
Target |
Action inhibitors |
Mechanism PRMT5 inhibitors(Protein arginine methyltransferase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urothelial Carcinoma of the Urinary Bladder | Preclinical | United States | 29 Apr 2025 | |
Urothelial Carcinoma of the Urinary Bladder | Preclinical | United States | 29 Apr 2025 | |
Urothelial Carcinoma of the Urinary Bladder | Preclinical | United States | 29 Apr 2025 |